Your browser doesn't support javascript.
loading
Cancer Evolution: A Multifaceted Affair.
Ciriello, Giovanni; Magnani, Luca; Aitken, Sarah J; Akkari, Leila; Behjati, Sam; Hanahan, Douglas; Landau, Dan A; Lopez-Bigas, Nuria; Lupiáñez, Darío G; Marine, Jean-Christophe; Martin-Villalba, Ana; Natoli, Gioacchino; Obenauf, Anna C; Oricchio, Elisa; Scaffidi, Paola; Sottoriva, Andrea; Swarbrick, Alexander; Tonon, Giovanni; Vanharanta, Sakari; Zuber, Johannes.
Affiliation
  • Ciriello G; Swiss Cancer Center Leman, Lausanne, Switzerland.
  • Magnani L; Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.
  • Aitken SJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Akkari L; Breast Epigenetic Plasticity and Evolution Laboratory, Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom.
  • Behjati S; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
  • Hanahan D; Medical Research Council Toxicology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Landau DA; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Lopez-Bigas N; Division of Tumor Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Lupiáñez DG; Wellcome Sanger Institute, Hinxton, United Kingdom.
  • Marine JC; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Martin-Villalba A; Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom.
  • Natoli G; Swiss Cancer Center Leman, Lausanne, Switzerland.
  • Obenauf AC; Ludwig Institute for Cancer Research, Lausanne, Switzerland.
  • Oricchio E; New York Genome Center, New York, New York.
  • Scaffidi P; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
  • Sottoriva A; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York.
  • Swarbrick A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Tonon G; Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
  • Vanharanta S; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
  • Zuber J; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, Berlin, Germany.
Cancer Discov ; 14(1): 36-48, 2024 01 12.
Article in En | MEDLINE | ID: mdl-38047596
ABSTRACT
Cancer cells adapt and survive through the acquisition and selection of molecular modifications. This process defines cancer evolution. Building on a theoretical framework based on heritable genetic changes has provided insights into the mechanisms supporting cancer evolution. However, cancer hallmarks also emerge via heritable nongenetic mechanisms, including epigenetic and chromatin topological changes, and interactions between tumor cells and the tumor microenvironment. Recent findings on tumor evolutionary mechanisms draw a multifaceted picture where heterogeneous forces interact and influence each other while shaping tumor progression. A comprehensive characterization of the cancer evolutionary toolkit is required to improve personalized medicine and biomarker discovery.

SIGNIFICANCE:

Tumor evolution is fueled by multiple enabling mechanisms. Importantly, genetic instability, epigenetic reprogramming, and interactions with the tumor microenvironment are neither alternative nor independent evolutionary mechanisms. As demonstrated by findings highlighted in this perspective, experimental and theoretical approaches must account for multiple evolutionary mechanisms and their interactions to ultimately understand, predict, and steer tumor evolution.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Limits: Humans Language: En Journal: Cancer Discov Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Limits: Humans Language: En Journal: Cancer Discov Year: 2024 Document type: Article Affiliation country: